Diagnostic and Biotech

Global Gastrointestinal Therapeutics Market 2016-2020

  • TEC705036
  • 102 Pages
  • September 2016
  • Diagnostic and Biotech
About Gastrointestinal Disorders

Gastrointestinal disorders include both functional and motility disorders affecting the gastrointestinal tract. Functional disorders involve an abnormality in the working of the gastrointestinal tract. They are the most common type of disorders and present with disturbances in motility, visceral hypersensitivity, changes in the mucosal and immune function, variations in central nervous system processing, and altered gut microbiota. Motility disorders are characterized by changes in the movement of the gastrointestinal tract and the transfer of its contents. Some of the most common gastrointestinal functional and motility disorders include IBS, GERD, Crohns disease, ulcerative colitis, and peptic ulcers.

Technavios analysts forecast the global gastrointestinal therapeutics market to grow at a CAGR of 6.5% during the period 2016-2020.

Covered in this report
The report covers the present scenario and the growth prospects of the global gastrointestinal therapeutics market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of branded, generic, and off-label drugs used for the treatment of various gastrointestinal disorders including IBD, and irritable bowel syndrome (IBS).

The market is divided into the following segments based on geography:
Americas
APAC
EMEA

Technavio's report, Global Gastrointestinal Therapeutics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
AbbVie
Johnson & Johnson
Takeda
Allergan
UCB

Other prominent vendors
4SC
Ajinomoto Pharmaceuticals
Alfa Wassermann
Alizyme
Amgen
Anterogen
Ardelyx
Arena Pharmaceuticals
Astellas
AstraZeneca
Astellas Pharma
Avaxia Biologics
Biogen Idec
BioLineRx
Celgene
ChemoCentryx
Cosmo Pharmaceuticals
Drais Pharmaceuticals
Eisai
Eli Lilly
Enlivex Therapeutics
F. Hoffmann-La Roche
Ferring Pharmaceuticals
FF Pharma
Galapagos
Gilead Sciences
GlaxoSmithKline
Hutchison Medi Pharma
Immune Pharmaceuticals
InDex Pharmaceuticals
Ironwood Pharmaceuticals
Kaken Pharmaceutical
Kang Stem Biotech
Kissei Pharmaceutical
Kyowa Hakko Kirin
Lexicon Pharmaceuticals
Lipid Therapeutics
Meda
Merck
Mesoblast
Mitsubishi Tanabe
Mochida Pharmaceutical
Morphotek
Neovacs
Nestle
Norgine
Novartis
Ono Pharmaceutical
Pfizer
Procter & Gamble
Qu Biologics
Receptos
RedHill Biopharma
Salix Pharmaceuticals
Shield Therapeutics
Sterna Biologicals
Synergy Pharmaceuticals
Synthetic Biologics
TiGenix
Tillotts Pharma
TopiVert
TSD Japan
Zeria Pharmaceutical

Market driver
Tentative approval of late stage molecules
For a full, detailed list, view our report

Market challenge
Discontinuation of drugs under development and from the market
For a full, detailed list, view our report

Market trend
Emergence of biosimilars
For a full, detailed list, view our report

Key questions answered in this report
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analysts time when you purchase this market report. Details are provided within the report.










Please Select Format

Enquiry About Report

Need More Information

Contact us
+ 1-800-910-6452
+1-971-202-1575
+91 20 66346066
--- or ---
help@bigmarketresearch.com

 

UPCOMING MARKET RESEARCH REPORTS

European NGS Services Market - Opportunities and Forecasts, 2015 - 2020

Next Generation Sequencing (NGS) services, also known as high-throughput sequencing, is term used to describe sequencing technologies, such as Illumina sequencing, Roche 454 sequencing, and SOLiD sequencing. These technologies enable ...

July 2017 | $3390 | Pre Book Price:$2967

World Surface Analysis Market - Opportunities and Forecasts, 2014 - 2020

Surface analysis is a technique that provides a medium to correlate performance with thin film conformation. The analysis is used in the discovery of new materials and to enhance the ...

July 2017 | $5370 | Pre Book Price:$4699

World Electrophoresis Market - Opportunities and Forecasts, 2015 - 2020

Electrophoresis is a technique used for separation of proteins and nucleic acids. This technique is primarily used for RNA and DNA analysis. It is also used in biochemistry for separation ...

July 2017 | $5370 | Pre Book Price:$4699

World Oxidative Stress Assay Market - Opportunities and Forecasts, 2015 - 2020

Oxidative stress assay is used to determine level of oxidative stress markers and reagents in cells. Applications of oxidative stress assay are research laboratories and bioproduction. Assays detect generalized oxidative ...

July 2017 | $5370 | Pre Book Price:$4699

European Microscopy Market - Opportunities and Forecasts, 2015 - 2020

Microscopy is a field of science in which objects are not visible to bare eye can be viewed under microscope. It is used to observe macromolecules and macromolecular complexes at ...

July 2017 | $3390 | Pre Book Price:$2967

World Immunoassay Market - Opportunities and Forecasts, 2015 - 2020

Immunoassay is a test conducted to determine concentration of macromolecule in a solution using antibody or immunoglobulin. The macromolecule detected is known as analyte. Immunoassay is used to measure quantity ...

July 2017 | $5370 | Pre Book Price:$4699

2017 © Copyright Big Market Research

View Pricing >>